Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy

Duchenne muscular dystrophy (DMD) is caused by the absence of the dystrophin protein and a properly functioning dystrophin-associated protein complex (DAPC) in muscle cells. DAPC components act as molecular scaffolds coordinating the assembly of various signaling molecules including ion channels. DMD shows a significant change in the functioning of the ion channels of the sarcolemma and intracellular organelles and, above all, the sarcoplasmic reticulum and mitochondria regulating ion homeostasis, which is necessary for the correct excitation and relaxation of muscles. This review is devoted to the analysis of current data on changes in the structure, functioning, and regulation of the activity of ion channels in striated muscles in DMD and their contribution to the disruption of muscle function and the development of pathology. We note the prospects of therapy based on targeting the channels of the sarcolemma and organelles for the correction and alleviation of pathology, and the problems that arise in the interpretation of data obtained on model dystrophin-deficient objects.

[1]  K. Belosludtsev,et al.  BKCa Activator NS1619 Improves the Structure and Function of Skeletal Muscle Mitochondria in Duchenne Dystrophy , 2022, Pharmaceutics.

[2]  A. Tinker,et al.  The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction , 2022, Communications Biology.

[3]  D. Kass,et al.  Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy , 2022, JCI insight.

[4]  J. C. Calderón,et al.  Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research , 2022, Frontiers in Physiology.

[5]  K. Belosludtsev,et al.  The Effect of Uridine on the State of Skeletal Muscles and the Functioning of Mitochondria in Duchenne Dystrophy , 2022, International journal of molecular sciences.

[6]  E. Gottlieb,et al.  Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients , 2022, International journal of molecular sciences.

[7]  A. Michelucci,et al.  Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy , 2022, The Journal of general physiology.

[8]  Jessica L. Braun,et al.  Sarco(endo)plasmic reticulum Ca2+-ATPase function is impaired in skeletal and cardiac muscles from young DBA/2J mdx mice , 2022, iScience.

[9]  C. G. Perry,et al.  Mitochondrial Stress Responses in Duchenne muscular dystrophy: Metabolic Dysfunction or Adaptive Reprogramming? , 2022, American journal of physiology. Cell physiology.

[10]  K. Belosludtsev,et al.  Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice , 2022, Bulletin of Experimental Biology and Medicine.

[11]  E. Pierantozzi,et al.  The Sarcoplasmic Reticulum of Skeletal Muscle Cells: A Labyrinth of Membrane Contact Sites , 2022, Biomolecules.

[12]  F. Salloum,et al.  Cardiovascular Disease in Duchenne Muscular Dystrophy , 2022, JACC. Basic to translational science.

[13]  G. Tremblay,et al.  CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy , 2022, Neurotherapeutics.

[14]  G. Babu,et al.  Reducing sarcolipin expression improves muscle metabolism in mdx mice. , 2022, American journal of physiology. Cell physiology.

[15]  P. Pinton,et al.  Molecular mechanisms and consequences of mitochondrial permeability transition , 2021, Nature Reviews Molecular Cell Biology.

[16]  T. Larcher,et al.  TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD , 2021, Journal of translational medicine.

[17]  G. Messina,et al.  Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies. , 2021, Experimental cell research.

[18]  F. Rivier,et al.  Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients , 2021, International journal of molecular sciences.

[19]  H. Sakurai,et al.  Orai1–STIM1 Regulates Increased Ca2+ Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells , 2021, Biomedicines.

[20]  K. Belosludtsev,et al.  Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis , 2021, International journal of molecular sciences.

[21]  K. Belosludtsev,et al.  Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient mdx Mice , 2021, Biomedicines.

[22]  E. Ignatieva,et al.  Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype , 2021, International journal of molecular sciences.

[23]  E. Clementi,et al.  Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy. , 2021, Pharmacological research.

[24]  B. Attali,et al.  Targeting of Potassium Channels in Cardiac Arrhythmias. , 2021, Trends in pharmacological sciences.

[25]  D. Duan,et al.  Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies , 2021, Frontiers in Physiology.

[26]  A. Zimna,et al.  The role of mitochondria in Duchenne muscular dystrophy. , 2021, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[27]  Zachary J. Crowley-McHattan,et al.  A Review of the Role of Endo/Sarcoplasmic Reticulum-Mitochondria Ca2+ Transport in Diseases and Skeletal Muscle Function , 2021, International journal of environmental research and public health.

[28]  V. Mouly,et al.  Treatment with a triazole inhibitor of the mitochondrial permeability transition pore fully corrects the pathology of sapje zebrafish lacking dystrophin. , 2021, Pharmacological research.

[29]  J. Rieusset,et al.  Metformin Reverses the Enhanced Myocardial SR/ER–Mitochondria Interaction and Impaired Complex I-Driven Respiration in Dystrophin-Deficient Mice , 2021, Frontiers in Cell and Developmental Biology.

[30]  Lai-Hua Xie,et al.  Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice. , 2020, American journal of physiology. Heart and circulatory physiology.

[31]  K. Belosludtsev,et al.  The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy , 2020, International journal of molecular sciences.

[32]  C. G. Perry,et al.  Mitochondrial bioenergetic dysfunction in the D2.mdx model of Duchenne muscular dystrophy is associated with microtubule disorganization in skeletal muscle , 2020, PloS one.

[33]  E. Olson,et al.  Gene Therapy with the DWORF Micropeptide Attenuates Cardiomyopathy in Mice. , 2020, Circulation research.

[34]  K. Belosludtsev,et al.  Transport of Ca2+ and Ca2+-dependent permeability transition in heart mitochondria in the early stages of Duchenne muscular dystrophy. , 2020, Biochimica et biophysica acta. Bioenergetics.

[35]  J. Mendell,et al.  Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy , 2020, JAMA neurology.

[36]  G. Aguiari,et al.  The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[37]  C. Xie,et al.  Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis , 2020, BioMed research international.

[38]  J. Wojcik,et al.  Protective effects of rimeporide on left ventricular function in golden retriever muscular dystrophy dogs. , 2020, International journal of cardiology.

[39]  J. Kira,et al.  iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin , 2020, BMC Musculoskeletal Disorders.

[40]  Jose A. Adams,et al.  Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice , 2020, Frontiers in Physiology.

[41]  R. Hajjar,et al.  Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  K. Belosludtsev,et al.  Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[43]  S. Robson,et al.  Total absence of dystrophin expression exacerbates ectopic myofiber calcification, fibrosis, and alters macrophage infiltration patterns. , 2019, The American journal of pathology.

[44]  Lai-Hua Xie,et al.  Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy. , 2019, American journal of physiology. Cell physiology.

[45]  S. Nelson,et al.  Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models , 2019, Molecular therapy. Nucleic acids.

[46]  K. Belosludtsev,et al.  Mitochondrial Ca2+ Transport: Mechanisms, Molecular Structures, and Role in Cells , 2019, Biochemistry (Moscow).

[47]  M. Puurand,et al.  On the role of tubulin, plectin, desmin, and vimentin in the regulation of mitochondrial energy fluxes in muscle cells. , 2019, American journal of physiology. Cell physiology.

[48]  U. Schlattner,et al.  Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylation , 2019, Journal of cachexia, sarcopenia and muscle.

[49]  J. Metzger,et al.  Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca2+ cycling in vivo. , 2018, American journal of physiology. Heart and circulatory physiology.

[50]  P. Pinton,et al.  IP3 receptor blockade restores autophagy and mitochondrial function in skeletal muscle fibers of dystrophic mice. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[51]  K. Hilber,et al.  Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart , 2018, International journal of molecular sciences.

[52]  A. Nakamura,et al.  Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition. , 2018, Biochemical and biophysical research communications.

[53]  J. Quadrilatero,et al.  Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology , 2018, Human molecular genetics.

[54]  Z. Bhat,et al.  ABC of multifaceted dystrophin glycoprotein complex (DGC) , 2018, Journal of cellular physiology.

[55]  R. González-Ramírez,et al.  Biochemical and Functional Interplay Between Ion Channels and the Components of the Dystrophin-Associated Glycoprotein Complex , 2018, The Journal of Membrane Biology.

[56]  E. Conte,et al.  Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  M. Antal,et al.  SOCE Is Important for Maintaining Sarcoplasmic Calcium Content and Release in Skeletal Muscle Fibers. , 2017, Biophysical journal.

[58]  P. Bernardi,et al.  Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy , 2017, Pharmacological research.

[59]  J. McArdle,et al.  Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice , 2017, Nature Communications.

[60]  S. Matecki,et al.  ER stress disturbs SR/ER-mitochondria Ca2+ transfer: Implications in Duchenne muscular dystrophy. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[61]  Andrew W. Trafford,et al.  Calcium and Excitation-Contraction Coupling in the Heart , 2017, Circulation research.

[62]  A. M. Leone,et al.  A current approach to heart failure in Duchenne muscular dystrophy , 2017, Heart.

[63]  N. Hempel,et al.  Mitochondria control store‐operated Ca2+ entry through Na+ and redox signals , 2017, The EMBO journal.

[64]  K. Hilber,et al.  Decreased inward rectifier potassium current IK1 in dystrophin-deficient ventricular cardiomyocytes , 2016, Channels.

[65]  M. Periasamy,et al.  Sarcolipin: A Key Thermogenic and Metabolic Regulator in Skeletal Muscle , 2016, Trends in Endocrinology & Metabolism.

[66]  Reija Autio,et al.  Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress. , 2016, Free radical biology & medicine.

[67]  David W. Hammers,et al.  Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts , 2016, Journal of the American Heart Association.

[68]  D. Garry,et al.  Dystrophin-Deficient Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[69]  A. Manzur,et al.  Corticosteroids for the treatment of Duchenne muscular dystrophy. , 2016, The Cochrane database of systematic reviews.

[70]  R. Hajjar,et al.  Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels. , 2016, Cell calcium.

[71]  U. Giovanella,et al.  Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle , 2016, Development.

[72]  M. Periasamy,et al.  Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase? , 2016, Journal of molecular and cellular cardiology.

[73]  H. Cai,et al.  Adenosine triphosphate-sensitive potassium channels and cardiomyopathies (Review). , 2016, Molecular medicine reports.

[74]  Stephen C. Cannon,et al.  A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle , 2016, Science.

[75]  D. Allen,et al.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. , 2016, Physiological reviews.

[76]  C. Bruno,et al.  Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis. , 2015, The American journal of pathology.

[77]  S. Cooper,et al.  Membrane Injury and Repair in the Muscular Dystrophies , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[78]  R. Perlingeiro,et al.  Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo , 2015, Molecular therapy. Methods & clinical development.

[79]  A. Teti,et al.  P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy , 2015, PLoS medicine.

[80]  J. Wilkinson,et al.  Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice , 2015, PloS one.

[81]  H. Takeshima,et al.  New and notable ion‐channels in the sarcoplasmic/endoplasmic reticulum: do they support the process of intracellular Ca2+ release? , 2015, The Journal of physiology.

[82]  R. Janicek,et al.  Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy. , 2015, Cell calcium.

[83]  M. Kuum,et al.  Potassium fluxes across the endoplasmic reticulum and their role in endoplasmic reticulum calcium homeostasis. , 2015, Cell calcium.

[84]  E. McNally,et al.  The Dystrophin Complex: Structure, Function, and Implications for Therapy. , 2015, Comprehensive Physiology.

[85]  J. Molkentin,et al.  Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy , 2015, Cell Death and Differentiation.

[86]  J. Molkentin,et al.  SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. , 2015, American journal of physiology. Cell physiology.

[87]  Jeovanna Lowe,et al.  Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy , 2015, PloS one.

[88]  John M. Shelton,et al.  A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance , 2015, Cell.

[89]  Andrew D. Williams,et al.  Defects in Mitochondrial ATP Synthesis in Dystrophin-Deficient Mdx Skeletal Muscles May Be Caused by Complex I Insufficiency , 2014, PloS one.

[90]  Jose A. Adams,et al.  Age-dependent changes in diastolic Ca(2+) and Na(+) concentrations in dystrophic cardiomyopathy: Role of Ca(2+) entry and IP3. , 2014, Biochemical and biophysical research communications.

[91]  J. Molkentin,et al.  Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy. , 2014, Human molecular genetics.

[92]  L. Hool,et al.  Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart , 2014, Proceedings of the National Academy of Sciences.

[93]  L. Tian,et al.  Gene expression profiling of Duchenne muscular dystrophy reveals characteristics along disease progression. , 2014, Genetics and molecular research : GMR.

[94]  G. Obermair,et al.  Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. , 2014, American journal of physiology. Heart and circulatory physiology.

[95]  B. Constantin Dystrophin complex functions as a scaffold for signalling proteins. , 2014, Biochimica et biophysica acta.

[96]  D. Kass,et al.  Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.

[97]  D. Kass,et al.  Hyperactive Adverse Mechanical Stress Responses in Dystrophic Heart Are Coupled to Transient Receptor Potential Canonical 6 and Blocked by cGMP–Protein Kinase G Modulation , 2014, Circulation research.

[98]  C. Henríquez-Olguín,et al.  Nifedipine Treatment Reduces Resting Calcium Concentration, Oxidative and Apoptotic Gene Expression, and Improves Muscle Function in Dystrophic mdx Mice , 2013, PloS one.

[99]  S. Boncompagni,et al.  Orai1-dependent Calcium Entry Promotes Skeletal Muscle Growth and Limits Fatigue , 2013, Nature Communications.

[100]  S. Moro,et al.  The mitochondrial calcium uniporter is a multimer that can include a dominant‐negative pore‐forming subunit , 2013, The EMBO journal.

[101]  Jerry R Mendell,et al.  Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy , 2013, Muscle & nerve.

[102]  D. Fraidenraich,et al.  Increased sarcolipin expression and decreased sarco(endo)plasmic reticulum Ca2+ uptake in skeletal muscles of mouse models of Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.

[103]  Y. Mori,et al.  Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+/calmodulin‐dependent kinase II , 2013, The Journal of physiology.

[104]  N. Déliot,et al.  Involvement of TRPV2 and SOCE in calcium influx disorder in DMD primary human myotubes with a specific contribution of α1-syntrophin and PLC/PKC in SOCE regulation. , 2013, American journal of physiology. Cell physiology.

[105]  E. Niggli,et al.  Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. , 2013, Cardiovascular research.

[106]  Carthene R. Bazemore-Walker,et al.  In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM). , 2013, Journal of proteomics.

[107]  Xiaoli Zhao,et al.  Orai1 Mediates Exacerbated Ca2+ Entry in Dystrophic Skeletal Muscle , 2012, PloS one.

[108]  M. Falzarano,et al.  The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms , 2012, PloS one.

[109]  F. Sbrana,et al.  Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy , 2012, Science Signaling.

[110]  Kevin M Flanigan,et al.  The Muscular Dystrophies , 1999, Seminars in Neurology.

[111]  T. Molinski,et al.  Increased Resting Intracellular Calcium Modulates NF-κB-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes* , 2012, The Journal of Biological Chemistry.

[112]  M. Weber,et al.  Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone , 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[113]  H. Lochmüller,et al.  P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment , 2012, Journal of cellular and molecular medicine.

[114]  H. Hosoi,et al.  The Shortest Isoform of Dystrophin (Dp40) Interacts with a Group of Presynaptic Proteins to Form a Presumptive Novel Complex in the Mouse Brain , 2012, Molecular Neurobiology.

[115]  Y. Jan,et al.  Activity of the mitochondrial calcium uniporter varies greatly between tissues , 2012, Nature Communications.

[116]  Kumaraswamy Nanthakumar,et al.  Role of KATP Channels in the Maintenance of Ventricular Fibrillation in Cardiomyopathic Human Hearts , 2011, Circulation research.

[117]  L. Tessarollo,et al.  Dystrophin Is Required for the Normal Function of the Cardio-Protective KATP Channel in Cardiomyocytes , 2011, PloS one.

[118]  R. Hajjar,et al.  SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice , 2011, Journal of Translational Medicine.

[119]  I. Ambudkar,et al.  Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .

[120]  V. Mootha,et al.  Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.

[121]  Ju Chen,et al.  The costamere bridges sarcomeres to the sarcolemma in striated muscle. , 2011, Progress in pediatric cardiology.

[122]  Ching-On Wong,et al.  cAMP Activates TRPC6 Channels via the Phosphatidylinositol 3-Kinase (PI3K)-Protein Kinase B (PKB)-Mitogen-activated Protein Kinase Kinase (MEK)-ERK1/2 Signaling Pathway* , 2011, The Journal of Biological Chemistry.

[123]  R. Hajjar,et al.  Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. , 2011, The Journal of clinical investigation.

[124]  C. Matsumura,et al.  Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF‐β1 blocker , 2011, Muscle & nerve.

[125]  C. Bourcier-Lucas,et al.  Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. , 2011, American journal of physiology. Heart and circulatory physiology.

[126]  J. Molkentin,et al.  Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice , 2010, Neuromuscular Disorders.

[127]  R. Gejman,et al.  Abnormal distribution of inositol 1,4,5‐trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy‐derived cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[128]  F. von Wegner,et al.  Upregulation of store-operated Ca2+ entry in dystrophic mdx mouse muscle. , 2010, American journal of physiology. Cell physiology.

[129]  J. Kornegay,et al.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.

[130]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[131]  S. Matecki,et al.  Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.

[132]  C. Cognard,et al.  Regulation by scaffolding proteins of canonical transient receptor potential channels in striated muscle , 2009, Journal of Muscle Research and Cell Motility.

[133]  V. Shoshan-Barmatz,et al.  NCLX is an essential component of mitochondrial Na+/Ca2+ exchange , 2009, Proceedings of the National Academy of Sciences.

[134]  Jonathan T. Pierce-Shimomura,et al.  The Dystrophin Complex Controls BK Channel Localization and Muscle Activity in Caenorhabditis elegans , 2009, PLoS genetics.

[135]  B. Aronow,et al.  Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.

[136]  R. Matsuda,et al.  Ectopic calcification is caused by elevated levels of serum inorganic phosphate in mdx mice. , 2009, Cell structure and function.

[137]  C. Cognard,et al.  Regulation of TRPC1 and TRPC4 Cation Channels Requires an α1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes* , 2009, The Journal of Biological Chemistry.

[138]  D. Clapham,et al.  Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter , 2009, Science.

[139]  M. Marques,et al.  Sarcoplasmic–endoplasmic–reticulum Ca2+‐ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin‐deficient mdx mice , 2009, Muscle & nerve.

[140]  A. R. Tupling The decay phase of Ca2+ transients in skeletal muscle: regulation and physiology. , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[141]  Yuji Arai,et al.  Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. , 2009, Human molecular genetics.

[142]  S. Matecki,et al.  Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.

[143]  C. Matsumura,et al.  Diltiazem and verapamil protect dystrophin‐deficient muscle fibers of MDX mice from degeneration: A potential role in calcium buffering and sarcolemmal stability , 2009, Muscle & nerve.

[144]  D. Gillespie,et al.  Intracellular calcium release channels mediate their own countercurrent: the ryanodine receptor case study. , 2008, Biophysical journal.

[145]  O. Dorchies,et al.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy , 2008, British journal of pharmacology.

[146]  Elisabetta Cerbai,et al.  Role of potassium currents in cardiac arrhythmias. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[147]  U. Ruegg,et al.  Nav1.4 Deregulation in Dystrophic Skeletal Muscle Leads to Na+ Overload and Enhanced Cell Death , 2008, The Journal of general physiology.

[148]  D. Allen,et al.  TRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophy , 2008, Journal of Cell Science.

[149]  H. Sweeney,et al.  Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy , 2008, Nature Medicine.

[150]  E. Niggli,et al.  Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. , 2008, Cardiovascular research.

[151]  E. Olson,et al.  Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[152]  Y. Katanosaka,et al.  Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors. , 2007, The American journal of pathology.

[153]  G. Billman,et al.  Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. , 2007, Journal of molecular and cellular cardiology.

[154]  J. Gillis,et al.  In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin‐lacking mdx mice , 2007, The Journal of physiology.

[155]  T. Ogura,et al.  TRIC channels are essential for Ca2+ handling in intracellular stores , 2007, Nature.

[156]  Joseph P. Yuan,et al.  STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels , 2007, Nature Cell Biology.

[157]  Tobias Meyer,et al.  Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2+ store depletion , 2007, Proceedings of the National Academy of Sciences.

[158]  M. Periasamy,et al.  Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. , 2007, Journal of molecular and cellular cardiology.

[159]  Anuradha Kalyanasundaram,et al.  SERCA pump isoforms: Their role in calcium transport and disease , 2007, Muscle & nerve.

[160]  C. Cognard,et al.  Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[161]  P. Várnai,et al.  Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.

[162]  B. Wong,et al.  Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers , 2006, Neuromuscular Disorders.

[163]  G. Salido,et al.  Interaction of STIM1 with Endogenously Expressed Human Canonical TRP1 upon Depletion of Intracellular Ca2+ Stores* , 2006, Journal of Biological Chemistry.

[164]  Patrick Ruchat,et al.  Cardiac Sodium Channel Nav1.5 Is Regulated by a Multiprotein Complex Composed of Syntrophins and Dystrophin , 2006, Circulation research.

[165]  B. Allard Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres , 2006, Journal of Muscle Research & Cell Motility.

[166]  S. Wagner,et al.  STIM1, an essential and conserved component of store-operated Ca2+ channel function , 2005, The Journal of cell biology.

[167]  A. Kurosky,et al.  TRPC1 forms the stretch-activated cation channel in vertebrate cells , 2005, Nature Cell Biology.

[168]  G. Mironova,et al.  Functional Distinctions between the Mitochondrial ATP-dependent K+ Channel (mitoKATP) and Its Inward Rectifier Subunit (mitoKIR)* , 2004, Journal of Biological Chemistry.

[169]  Yuan-Ping Pang,et al.  ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating , 2004, Nature Genetics.

[170]  Susan C. Brown,et al.  Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion , 2004, Neurobiology of Disease.

[171]  S. Carbonetto,et al.  Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. , 2003, Human molecular genetics.

[172]  K. Dietzmann,et al.  Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse , 1998, Molecular and Cellular Biochemistry.

[173]  T. Gudermann,et al.  N-Linked Protein Glycosylation Is a Major Determinant for Basal TRPC3 and TRPC6 Channel Activity* , 2003, Journal of Biological Chemistry.

[174]  A. Colell,et al.  Cholesterol Impairs the Adenine Nucleotide Translocator-mediated Mitochondrial Permeability Transition through Altered Membrane Fluidity* , 2003, Journal of Biological Chemistry.

[175]  Yuji Arai,et al.  A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor–regulated channel , 2003, The Journal of cell biology.

[176]  K. Ohlendieck,et al.  Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. , 2003, European journal of cell biology.

[177]  C. Cognard,et al.  Na+/Ca2+ exchange in human myotubes: intracellular calcium rises in response to external sodium depletion are enhanced in DMD , 2002, Neuromuscular Disorders.

[178]  H. Debaix,et al.  Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers , 2002, The Journal of cell biology.

[179]  Andrew P. Weir,et al.  Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.

[180]  M. Bucan,et al.  Running endurance abnormality in mdx mice , 2002, Muscle & nerve.

[181]  Lawrence Salkoff,et al.  SLO-1 Potassium Channels Control Quantal Content of Neurotransmitter Release at the C. elegans Neuromuscular Junction , 2001, Neuron.

[182]  A. Comtois,et al.  Dystrophin‐deficient cardiomyocytes are abnormally vulnerable to mechanical stress‐induced contractile failure and injury , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[183]  C. Cognard,et al.  Cationic channels in normal and dystrophic human myotubes , 2001, Neuromuscular Disorders.

[184]  L. Salkoff,et al.  SLO-2, a K+ channel with an unusual Cl− dependence , 2000, Nature Neuroscience.

[185]  B. Allard,et al.  Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[186]  C. Schöneich,et al.  Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. , 1999, Biochemistry.

[187]  C. Schöneich,et al.  Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. , 1999, The Biochemical journal.

[188]  K. Föhr,et al.  Increased calcium entry into dystrophin‐deficient muscle fibres of MDX and ADR‐MDX mice is reduced by ion channel blockers , 1999, The Journal of physiology.

[189]  J A Powell,et al.  Differences in both inositol 1,4,5‐trisphosphate mass and inositol 1,4,5‐trisphosphate receptors between normal and dystrophic skeletal muscle cell lines , 1998, Muscle & nerve.

[190]  J. Caldwell,et al.  Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins , 1998, The Journal of Neuroscience.

[191]  C. Schöneich,et al.  Identification of oxidation-sensitive peptides within the cytoplasmic domain of the sarcoplasmic reticulum Ca2+-ATPase. , 1997, Biochemistry.

[192]  B. Allard,et al.  Similarity of ATP‐dependent K+ channels in skeletal muscle fibres from normal and mutant mdx mice. , 1997, The Journal of physiology.

[193]  A. Hühmer,et al.  Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca‐ATPase of rat skeletal muscle during aging: a peroxynitrite‐mediated process? , 1996, FEBS letters.

[194]  R. Levi,et al.  Properties of cardiac cells from dystrophic mouse. , 1995, Journal of molecular and cellular cardiology.

[195]  E. Hoffman,et al.  Phospholipase A2 activity in dystrophinopathies , 1995, Neuromuscular Disorders.

[196]  R. Gilmour,et al.  Reduction of the transient outward potassium current in canine x‐linked muscular dystrophy , 1994, Circulation.

[197]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[198]  A. Torroni,et al.  Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. , 1992, The Journal of biological chemistry.

[199]  A. Emery Population frequencies of inherited neuromuscular diseases—A world survey , 1991, Neuromuscular Disorders.

[200]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[201]  A. Emery,et al.  Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. , 1980, British medical journal.